• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Antibacterial Peptide Spray Safe for Use on Wounds

      Antibacterial Peptide Spray Safe for Use on Wounds

      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

    • Radiology
      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

    • Cardiology
      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

    • Surgery
      Antibacterial Peptide Spray Safe for Use on Wounds

      Antibacterial Peptide Spray Safe for Use on Wounds

      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Global Retinal Vein Occlusion (RVO) Market Size Worth USD 25.8 Billion by 2030: Polaris Market Research

December 8th, 2022 Polaris Market Research Releases

Polaris Market Research recently published [115+ Pages] research report on “Retinal Vein Occlusion (RVO) Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO)); By Treatment; By Region; Segment Forecast, 2022 – 2030” in its research database.

According to the research report, the global retinal vein occlusion (RVO) market size was valued at USD 12.17 billion in 2021 and is expected to reach USD 25.8 Billion by 2030, growing at a CAGR of 8.8% during the forecast period.

What is Retinal Vein Occlusion (RVO)? What is the Expected Retinal Vein Occlusion (RVO) Market Size & Share?

  • Overview

Retinal vein occlusion (RVO) is a disorder in the retina caused due to the blockage of the small vein, which carries blood from the retina. The foremost symptom of this disorder is a sudden change of vision; it may include blurry vision or complete vision loss. The symptom of vision is major and takes place in only one eye. A person with high blood pressure, diabetes, and older age are the main targets of this disorder.

The retinal vein occlusion cannot be cured; doctors can’t unblock the retinal veins, but all they can do is treat any complication and save your vision. As the frequency of atherosclerosis, blood pressure, and diabetes are rising, it is anticipated to boost the retinal vein occlusion (RVO) market share over the foreseen period.

Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/retinal-vein-occlusion-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Key Highlights of the Report

  • A detailed analysis of the market and sub-market forecast
  • Extensive details and analysis of contracts, projects, and programs
  • Analysis of technological trends and how these shape the industry
  • The in-depth description of technical factors and political regulatory
  • Outline of leading companies operating within the sector
  • SWOT analysis of the major key players operating in the market, together with the opportunities available and the key threads faces

Some of the Top Market Players Are:

  • Ellex Medical Lasers
  • Bristol-Myers Squibb
  • Bayer
  • Allergen PLC
  • GlaxoSmithKline PLC
  • IRIDEX Corporation
  • Regeneron Pharmaceuticals
  • BioMedical Technologies
  • Carl Zeiss AG
  • NIDEK Co. LTD
  • Topcon Corporation

To Know Additional Information on Market Players, Download Sample PDF Brochure

Growth Driving Factors

  • Growing frequency of eye-related diseases is expected to fuel the industry

The retinal vein occlusion (RVO) market demand is rising due to growing ophthalmic diseases worldwide. The rising geriatric population with eyesight disorders combined with rising awareness regarding eye disorders is anticipated to propel the industry revenue share during the assessment period. The existence of a powerful pipeline and the latest drug approval is expected to fuel the market demand over the prediction period.

The increasing frequency of eye-related diseases worldwide is expected to boost the market. A rising understanding of eye diseases, growing healthcare facilities, and advancement in technology in the healthcare field are expected to propel the retinal vein occlusion (RVO) market size over the forecast period. Rising government initiatives towards the healthcare industry are expected to fuel the retinal vein occlusion industry and are expected to maintain its dominance during the assessment period.

Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/17211

Recent Developments

  • In December 2020, Arctic Vision, a clinical-stage ophthalmology company headquartered in China with a leading pipeline of breakthrough innovations, announced the approval of the Phase III Investigational New Drug (IND) for the treatment of Uveitic Macular Edema.
  • In September 2021, Samsung Bioepis received FDA approval to treat patients with macular degeneration illness and other eye disorders, including RVO. This clearance is anticipated to accelerate market expansion.

Segmental Analysis

  • The central retinal vein occlusion segment is considered as the highest market share

On the basis of disease type, the retinal vein occlusion (RVO) market segmentations are classified into Central Retinal Vein Occlusion (CRVO) and Branch Retinal Vein Occlusion (BRVO). Out of both, the central retinal vein occlusion segment dominated the market because the baseline visual acuity difference in CRVO and BRVO eyes ranges is 20/200 and 20/40, which is comparatively poor than BRVO. The visual accuracy of the CRVO eye usually declines without therapy. Most people suffering from CRVO have the symptoms of macular edema. Also, CRVO is a severe condition it may cause permanent injury to the retina and vision loss.

  • Anti-VEGF drugs segment dominated the market

On the basis of treatment, the anti-VEGF drugs segment accounted for the highest market share in 2021 and is anticipated to maintain its dominance over the foreseen period. The factors accountable for the segment’s dominance are that a drug category called anti-VEGF can moderate the development of new blood vessels in the retina. It is critical in angiogenesis and vasculogenesis. It is utilized to manage several eye diseases that result in swelling under the retina’s macular region.

Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/retinal-vein-occlusion-market/inquire-before-buying

(Inquire about a report quote OR available discount offers to the sales team before purchase.)

Retinal Vein Occlusion (RVO) Market: Report Scope

Report Attribute Details
Market Outlook for 2030 USD 25.8 Billion
Market Size 2022 Value USD 13.13 Billion
Expected CAGR Growth 8.8% from 2022 – 2030
Base Year 2021
Forecast Year 2022 – 2030
Top Market Players Ellex Medical Lasers, Bristol-Myers Squibb, Bayer, Allergen PLC, GlaxoSmithKline PLC, IRIDEX Corporation, Regeneron Pharmaceuticals, BioMedical Technologies, Carl Zeiss AG, NIDEK Co., LTD, Topcon Corporation.
Segments Covered By Disease Type, By Treatment, and By Region.
Customization Options Customized purchase options are available to meet your research needs. Explore customized purchase options

 Geographic Overview

  • North America is accounted for the significant market share

On a geographical basis, the North American region accounted for the highest market share in 2021 and is anticipated to maintain its dominance over the foreseen period. The factors accountable for the region’s dominance in the retinal vein occlusion (RVO) industry are the factors such as the USFDA’s acceptance of innovative anti-VEGF medicines in the United States, the pharmaceutical industry’s huge ophthalmology pipeline, and existing clinical studies for retinal illnesses.

Further, Asia Pacific is anticipated to dominate the market due to dynamic nations such as India being involved in the prevention and management of retinal disorders and blindness.

Browse the Detail Report “Retinal Vein Occlusion (RVO) Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO)); By Treatment; By Region; Segment Forecast, 2022 – 2030” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/retinal-vein-occlusion-market

For Additional Information OR Media Enquiry, Please Mail Us At: sales@polarismarketresearch.com

Retinal Vein Occlusion Market Report Highlights

  • Central retinal vein occlusion segment held the largest market share as there is a rising incidence of diabetes in the population that tends to cause visual impairment.
  • Anti-VEGF held the largest treatment segment due to the growing need to cure eye diseases that cause swelling.
  • North America held the dominant position because of rising eye diseases and lifestyle disorders like diabetes that disrupt the vision in long term.

Key Questions Answered in The Report Include:

  • What are the key factors driving the retinal vein occlusion (RVO) market?
  • What are the business growth strategies adopted by the developed and developing regions?
  • What are the key outcomes of the five forces analysis?
  • Who are the leading players active in the retinal vein occlusion (RVO) industry?
  • What’s the competition in this industry, both company, and country-wise?

Polaris Market Research has segmented the retinal vein occlusion market report based on disease type, treatment, and region:

By Disease Outlook

  • Central Retinal Vein Occlusion (CRVO)
  • Branch Retinal Vein Occlusion (BRVO)

By Treatment Outlook

  • Anti-vascular Endothelial Growth Factor (Anti-VEGF)
  • Corticosteroid Drugs
  • Others

By Regional Outlook

  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:

Likhil G

30 Wall Street

8th Floor,

New York City, NY 10005,

United States

Phone: +1-929 297-9727

Email: sales@polarismarketresearch.com

Web: https://www.polarismarketresearch.com

Follow US: LinkedIn | twitter

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email